Rigel (RIGL) Affirms Pricing 13.7M Offering at $9.50/Share

Rigel Pharmaceuticals, Inc. (NasdaqGS: RIGL), today announced the pricing of its previously announced underwritten public offering of 13,685,000 shares of its common stock, offered at a price of $9.50 per share to the public. The gross proceeds to Rigel from this offering are expected to be approximately $130.0 million, before deducting underwriting discounts and commissions, and other estimated offering expenses payable by Rigel. All of the shares in the offering are to be sold by Rigel. The offering is expected to close on or about October 9, 2012, subject to the satisfaction of customary closing conditions. Rigel has granted the underwriters a 30-day option to purchase up to an aggregate of 2,052,750 additional shares of common stock to cover overallotments, if any.

Jefferies& Company, Inc. and J.P. Morgan Securities LLC acted as joint book-running managers for the offering, Citigroup acted as lead manager and BMO Capital Markets, Piper Jaffray & Co. and Wells Fargo Securities, LLC acted as co-managers.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• ICE raises $3.71 billion in senior notes to fund MarketAxess deal
• SharonAI Holdings (SHAZ) files for 8.06M share offering by selling stockholders
• BKV Corporation (BKV) files for 5.315M share offering by selling stockholders